Replies to post #331621 on Avid Bioservices Inc (CDMO)

[biopharm]

Kathryn Packman
Sr. Scientific Director and Global Head of Tumor Biology at Janssen Pharmaceutical Companies of Johnson & Johnson

PS Targeting is HUGE ...is that not why Joseph Carleone was brought on board as Chair?

I didn't realize the patent was published with Kathryn Packman ...and others including Kelli J Glenn at SK Holdings

Some reading for the evening ....

________

PPHM - Peregrine Pharmaceuticals ...now being called Avid Bioservices CDMO had Chair of BOD Joseph Carleone and sat on AMPAC Fine Chemicals Board till August 2018 though Avid website still shows him Chair at AMPAC....which was shifted from HIG Capital to SK Holdings (which had lots of subsidiaries ...) including ties to Kelli Glenn at SK Life Sciences

___________

Joseph Carleone, Ph.D.

Chairman of the Board
Dr. Carleone is Chairman of the Board of AMPAC Fine Chemicals LLC, a leading manufacturer of pharmaceutical active ingredients.
....
....

http://ir.avidbio.com/board-directors/joseph-carleone

___________

Together AMPAC Fine Chemicals (USA) and SK biotek (South Korea and Ireland) offer an expanded value proposition in the worldwide CDMO space.

....
....

AMPAC Fine Chemicals â??AFCâ?? (recently acquired by SK Holdings) and SK biotek now offer expanded CDMO services across three continents, and with six manufacturing sites and one dedicated Analytical Testing facility, offer comprehensive capabilities that support all phases of drug development and commercialization.

https://ampacanalytical.com/wp-content/uploads/2018/11/AMPAC_SK-Fine-Chemicals.pdf

___________

SK life sciences a subsidiary of sk biopharmaceuticals

FDA accepts NDA for cenobamate

https://www.sklifescienceinc.com/about-us.html#/leadership

_________


AMPAC from HIG Capital to SK Holdings Corp( largest Korean Pharma deal)

July 16 2018

https://www.prnewswire.com/news-releases/ampac-fine-chemicals-to-be-acquired-by-sk-holdings-300680838.html

_________

Kelli J Glenn

Head of Toxicology/DMPK at SK Life Science

SK Life Science, Inc.
The Ohio State University

Greater New York City Area
487 connections

About
Toxicology, DMPK, and Bioanalytical department head who leads a group of dedicated scientists in developing drugs from Phase I through post-market. DMPK and bioanalytical subject matter expert (SME) for all development programs within the company.

...
...

Patents

Method for administration of an anti tumor agent

Issued September 26, 2013
United StatesWO2013139687 A1

There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels.

Other inventors

Brian Higgins
Kathryn Packman
Gwen Nichols

...
...

https://www.linkedin.com/in/kelliglenn

__________

Patents by Inventor Kathryn Packman
Kathryn Packman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

METHOD FOR ADMINISTRATION
Publication number: 20190328708

Abstract: There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.

Type: Application
Filed: July 12, 2019
Publication date: October 31, 2019

Inventors:

Kelli Glenn,
Brian Higgins,
Gwen Nichols,
Kathryn Packman

...
...

https://patents.justia.com/inventor/kathryn-packman

____________